<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>Pharmacological and Nanotechnological Approaches in the Treatment of Chronic Pain: Mechanisms, Innovations, and Future Directions</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Muradova Railya</mods:namePart><mods:namePart type="family">Rustamovna</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Chronic pain is a multifactorial and debilitating condition, often resistant to conventional pharmacological treatments. Despite significant advancements in pain management, patients continue to experience limited efficacy, significant side effects, and challenges in achieving optimal pain control. This article explores the pharmacological mechanisms behind chronic pain and the evolving role of nanotechnology in enhancing drug delivery and improving therapeutic outcomes. The integration of nanomedicine promises to overcome many limitations of current therapies by improving the bioavailability, targeting specificity, and reducing systemic toxicity. By synthesizing recent scientific work, this article highlights the growing promise of nanotechnology, alongside traditional pharmacological strategies, in revolutionizing chronic pain treatment.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-01-28</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>